Catelani Michael
President, COO, & CFO
Catelani Michael has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 30, 2026.
On the most recent filing, Catelani Michael is listed as President, COO, & CFO at Anixa Biosciences Inc. Inside the rolling window, Catelani Michael reported 1 open-market purchase totaling $16K in ANIX and no open-market sales.
Companies traded
Other insiders at ANIX
Insider Buying
$16K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Catelani Michael made?
Catelani Michael has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Catelani Michael trade?
Catelani Michael has filed SEC Form 4 disclosures for 1 company, including ANIX.
When was Catelani Michael's most recent SEC Form 4 filing?
Catelani Michael's most recent SEC Form 4 filing on Tracefour is dated Sep 30, 2026.
What is Catelani Michael's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Catelani Michael is listed as President, COO, & CFO.
What is Catelani Michael's total buy and sell value in the current window?
Inside the rolling retention window, Catelani Michael bought $16K and sold $0 based on SEC Form 4 filings.
What was Catelani Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 5,500 ANIX shares on 2026-09-30, worth $16K, per SEC Form 4 filings.